These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9520115)

  • 61. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Konishi H; Miyauchi K; Shitara J; Endo H; Wada H; Doi S; Naito R; Tsuboi S; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Am J Cardiol; 2016 Dec; 118(12):1781-1785. PubMed ID: 27712648
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).
    Afshar M; Pilote L; Dufresne L; Engert JC; Thanassoulis G
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108248
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction.
    Am J Cardiol; 1993 Feb; 71(5):393-400. PubMed ID: 8430625
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).
    Maher VM; Brown BG; Marcovina SM; Hillger LA; Zhao XQ; Albers JJ
    JAMA; 1995 Dec; 274(22):1771-4. PubMed ID: 7500507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.
    Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN
    Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.
    Durrington PN; Bhatnagar D; Mackness MI; Morgan J; Julier K; Khan MA; France M
    Heart; 2001 May; 85(5):544-8. PubMed ID: 11303007
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F; Sampietro T; Basta G; Giannasi G; Bionda A
    Minerva Med; 1995; 86(7-8):299-303. PubMed ID: 7478073
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
    de Lemos JA; Blazing MA; Wiviott SD; Lewis EF; Fox KA; White HD; Rouleau JL; Pedersen TR; Gardner LH; Mukherjee R; Ramsey KE; Palmisano J; Bilheimer DW; Pfeffer MA; Califf RM; Braunwald E;
    JAMA; 2004 Sep; 292(11):1307-16. PubMed ID: 15337732
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden.
    Glader CA; Birgander LS; Stenlund H; Dahlén GH
    J Intern Med; 2002 Jul; 252(1):27-35. PubMed ID: 12074735
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lysine-binding species of lipoprotein(a) in coronary artery disease.
    Karmansky I; Shnaider H; Palant A; Gruener N
    Eur J Clin Invest; 1994 May; 24(5):360-6. PubMed ID: 8088314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipoprotein [Lp(a)] and peripheral vascular disease.
    Tyrrell J; Cooke T; Reilly M; Colgan M; Moore D; Shanik DG; Bergin C; Feely J
    J Intern Med; 1992 Oct; 232(4):349-52. PubMed ID: 1402639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum LP(A) levels in randomized healthy men from different European countries.
    Cigolini M; Seidell JC; Zenti MG; Bonadonna G; Zambelli L; Deslypere JP; Contaldo F; Cruz A; Charzewska J; Targher G
    Eur J Epidemiol; 1993 Sep; 9(5):497-503. PubMed ID: 8307134
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study.
    Chien KL; Hsu HC; Su TC; Sung FC; Chen MF; Lee YT
    Clin Chem; 2008 Feb; 54(2):285-91. PubMed ID: 18089660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal.
    Boffa MB; Stranges S; Klar N; Moriarty PM; Watts GF; Koschinsky ML
    J Clin Lipidol; 2018; 12(6):1358-1366. PubMed ID: 30316749
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low lipoprotein(a) concentration is associated with cancer and all-cause deaths: a population-based cohort study (the JMS cohort study).
    Sawabe M; Tanaka N; Mieno MN; Ishikawa S; Kayaba K; Nakahara K; Matsushita S;
    PLoS One; 2012; 7(4):e31954. PubMed ID: 22485129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Postmenopausal Women: A Systematic Review.
    Masson W; Barbagelata L; Corral P; Nogueira JP; Lavalle-Cobo A; Belardo A
    Curr Probl Cardiol; 2023 Apr; 48(4):101589. PubMed ID: 36621517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.